Guidelines for ATC classification and DDD assignment - WHOCC

M01CA Quinolines
The DDDs are based on the treatment of rheumatoid arthritis.
Chloroquine and hydroxychloroquine are classified as antimalaria agents
in P01BA.
M01CB Gold preparations
M01CC Penicillamine and similar agents
M01CX Other specific antirheumatic agents
M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
This group comprises ointments, liniments, plasters, etc. which may
produce symptomatic relief in joint and muscular pain.
No DDDs have been assigned in this group.
M02AA Antiinflammatory preparations, non-steroids for topical use
All non-steroidal antiinflammatory derivatives for topical use are
classified here, regardless of indication. Exception is a product
containing diclofenac formulated as a 3 % hyaluronic acid gel which is
used in treatment of actinic keratoses. This particular formulation is
classified in D11AX.
Combinations of non-steroidal antiinflammatory derivatives and other
substances for topical use are classified together with plain preparations
at the different 5th levels.
M02AB Capsaicin and similar agents
Capsaicin products indicated for the symptomatic treatment of
peripheral neuropathic pain (incl. postherpetic neuralgia) are classified
in N01BX.
197